Home
Centers
Trials
Treatments
Search
Help
(888) 803-1766
Schedule Call
Live Chat
Email Us
Menu
Home
Centers
Trials
Treatments
(888) 803-1766
Schedule Call
Live Chat
Email Us
REM-422
Overview
Centers
Trials
Resources
Details
Overview
Centers
Trials
Resources
Details
Filters
Save & Share
Clear Filters
Show All Filters
Location
Add your Location
Explore options near your center - or near your patient's home.
Diagnosis
Myelodysplastic Syndromes
Clonal Hematopoiesis of Indeterminate Potential (CHIP)
Clonal Cytopenia of Undetermined Significance (CCUS)
Idiopathic Cytopenia of Unknown Significance (ICUS)
Purpose of Trial
All Trials
Trials to Treat MDS
Trials to Treat Symptoms of MDS
Observational Trials
Patient Support Trials
Transplant Support Trials
Imaging, Labs, Tests
Filter and find trials based on their purpose.
Patient Screener
Near
Add Your Location
Sorting
1
by
Sort by
Relevancy
Accepting patients
REM-422
A Phase 1, Multicenter, Open-Label Study of REM-422, an MYB mRNA Degrader, in Patients With Relapsed/Refractory AML or Higher-Risk MDS
Learn more
MYB mRNA Degrader
Phase 1
Showing
1-1
of
1